Book description
An expert's view on solving the challenges confronting today's
pharmaceutical industry
Author John LaMattina, a thirty-year veteran of the pharmaceutical
industry and former president of Pfizer's Global R&D Division, is
internationally recognized as an expert on the pharmaceutical
industry. His first book, Drug Truths: Dispelling the Myths About
Pharma R&D, was critically acclaimed for clearing up
misconceptions about the pharmaceutical industry and providing an
honest account of the contributions of pharmaceutical research and
development to human health and well-being.
As he toured the country discussing Drug Truths, Dr. LaMattina
regularly came across people who were filled with anger, accusing the
pharmaceutical industry of making up diseases, hiding dangerous side
effects, and more. This book was written in response to that
experience, critically examining public perceptions and industry realities.
Starting with "4 Secrets that Drug Companies Don't Want You to
Know," Devalued and Distrusted provides a fact-based
account of how the pharmaceutical industry works and the challenges it
faces. It addresses such critical issues as:
- Why pharmaceutical R&D productivity has declined
- Where pharmaceutical companies need to invest their resources
- What can be done to solve core health challenges, including
cancer, diabetes, and neurodegenerative diseases
- How the pharmaceutical industry can regain public trust and
resuscitate its image
Our understanding of human health and disease grows daily; however,
converting science into medicine is increasingly challenging. Reading
Devalued and Distrusted, you'll not only gain a greater
appreciation of those challenges, but also the role that the
pharmaceutical industry currently plays and can play in solving those challenges.
JOHN L. LaMATTINA, PHD, retired as president of Pfizer's Global
Research and Development in 2007, where he managed more than 13,000
scientists and support professionals in the United States, Europe, and
Asia. Dr. LaMattina has received numerous honors and awards, including
an Honorary Doctor of Science from the University of New Hampshire.
Currently a Senior Partner with PureTech Ventures, he is the author of
Drug Truths: Dispelling the Myths About Pharma R&D (Wiley).
